Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted protein degradation medicines, today ...

For millennia, aging has been viewed as an immutable, inevitable decline. However, a scientific revolution is underway, reframing aging not as a destiny to be ...

Glioblastoma multiforme (GBM) is the most aggressive and common type of brain cancer in adults, with a dismal prognosis despite current treatments. Previous work found that neurodevelopmental pathways ...

Every cell in the human body operates on an intricate internal schedule, governed by circadian rhythms that synchronize our ...

Ras, part of the RAS family of small GTPases, are among the most frequent oncogenic drivers in human cancers, with significant incidence in ...

Dr. Werner became interested in the question "What is life?" as a four-year old child in his parent's garden in former East Germany. At the age of 10, he began to develop a life-long interest in the ...

Editor's note: This article is part of a special package written for the 50th anniversary of the discovery of a 3.2 million-year-old A. afarensis fossil (AL 288-1), nicknamed "Lucy." About 3.2 million ...

Beijing DP Technology Co. Ltd. has divulged proteolysis targeting chimera (PROTAC) compounds comprising an E3 ubiquitin ligase-binding moiety covalently bonded to a Myc proto-oncogene protein ...

Oh, S. and Shin, J. (2025) Nedd4-1 as a Proliferating Factor in Uterine Cervical Carcinogenesis. Open Journal of Obstetrics and Gynecology, 15, 1640-1652. doi: 10.4236/ojog.2025.1510137 .